What is NextKidney?
NextKidney is a pioneering medical technology firm dedicated to the development and commercialization of the NeoKidney home hemodialysis device. The company operates at the intersection of advanced engineering and patient-centric healthcare, aiming to replace traditional, cumbersome dialysis methods with a safe, practical, and intuitive solution. By focusing on the user experience, NextKidney addresses the critical need for accessible, high-quality renal treatment that can be administered outside of clinical settings, thereby significantly improving the daily lives of patients suffering from chronic kidney disease.
How much funding has NextKidney raised?
NextKidney has raised a total of $8.4M across 1 funding round:
Series B
$8.4M
Series B (2023): $8.4M, investors not publicly disclosed
Key Investors in NextKidney
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for NextKidney?
With the infusion of this major strategic investment, NextKidney is poised to scale its operations and expedite the global rollout of its proprietary technology. The company is expected to focus on regulatory milestones, manufacturing optimization, and clinical validation to ensure the NeoKidney device meets the rigorous demands of international healthcare markets. As the firm transitions from development to commercialization, the focus will remain on establishing a robust supply chain and expanding its footprint within the global dialysis market, ultimately aiming to set a new standard for home-based renal care.
See full NextKidney company page
